eve Sleep plc
LSE:EVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
eve Sleep plc
LSE:EVE
|
UK |
|
D
|
Dalata Hotel Group PLC
ISEQ:DHG
|
IE |
|
U
|
Union Bank of the Philippines
XPHS:UBP
|
PH |
|
Qi An Xin Technology Group Inc
SSE:688561
|
CN |
|
K
|
Koios Beverage Corp
CNSX:FIT
|
CA |
|
On Holding AG
NYSE:ONON
|
CH |
|
Ambac Financial Group Inc
NYSE:AMBC
|
US |
|
Fuji Corp (Aichi)
TSE:6134
|
JP |
|
N
|
Nexeon Medsystems Inc
OTC:NXNN
|
US |
|
Excellence Commercial Property & Facilities Management Group Ltd
HKEX:6989
|
CN |
|
H
|
Hemant Surgical Industries Ltd
BSE:543916
|
IN |
|
Novem Group SA
XETRA:NVM
|
LU |
|
A
|
Anheuser-Busch Inbev SA
SWB:1NBA
|
BE |
Balance Sheet
Balance Sheet Decomposition
eve Sleep plc
eve Sleep plc
Balance Sheet
eve Sleep plc
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
2
|
5
|
27
|
6
|
8
|
8
|
5
|
|
| Cash Equivalents |
2
|
5
|
27
|
6
|
8
|
8
|
5
|
|
| Total Receivables |
0
|
1
|
3
|
3
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
1
|
2
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
3
|
1
|
1
|
1
|
0
|
|
| Inventory |
0
|
0
|
1
|
1
|
2
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
1
|
2
|
2
|
1
|
1
|
|
| Total Current Assets |
2
|
6
|
32
|
12
|
13
|
11
|
7
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
6
+213%
|
32
+421%
|
13
-61%
|
13
+6%
|
12
-10%
|
8
-31%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
2
|
4
|
3
|
3
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
0
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Total Current Liabilities |
0
|
3
|
5
|
6
|
5
|
5
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
3
+689%
|
5
+85%
|
6
+3%
|
5
-5%
|
5
+1%
|
4
-19%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
2
|
13
|
10
|
30
|
41
|
43
|
46
|
|
| Additional Paid In Capital |
3
|
16
|
37
|
37
|
49
|
49
|
50
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
3
+104%
|
27
+716%
|
7
-73%
|
8
+14%
|
7
-18%
|
4
-42%
|
|
| Total Liabilities & Equity |
2
N/A
|
6
+213%
|
32
+421%
|
13
-61%
|
13
+6%
|
12
-10%
|
8
-31%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
138
|
138
|
139
|
140
|
263
|
273
|
274
|
|